January is Alzheimer's Awareness Month in Canada. According to the Alzheimer's Association, almost 750,000 Canadians are ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone ...

Seasonal affective disorder (SAD) is a type of recurrent depressive periods that occur during the same season each year. SAD ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Scientific research and experts say the very common problem suffered by millions can be an early sign of Alzheimer's ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

Limbic-predominant age-related TDP-43 encephalopathy (LATE) is a recently characterized form of dementia that is distinct ...

They aim to track tiny changes in the retina of the eye that occur over time that could spot earliest signs of Alzheimer's years before symptoms develop. Alzheimer's is the leading cause of ...

High levels of “hidden” fat known as visceral fat may put you at higher risk for Alzheimer’s disease up to two decades before ...

A new diagnostic tool is being developed which could one day allow doctors to diagnose Alzheimer's disease through a simple ...